Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments

ClinicalTrials.gov ID: NCT00045877

Public ClinicalTrials.gov record NCT00045877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 8:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have previously failed Rituxan treatments.

Study identification

NCT ID
NCT00045877
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Chiron Corporation
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Feb 6, 2006

United States locations

U.S. sites
65
U.S. states
23
U.S. cities
60
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
California Oncology of the Central Valley Fresno California 93710 —
Virginia K. Crosson Cancer Center Fullerton California 92835 —
Pacific Shores Medical Group Glendale California 91204 —
Wilshire Oncology Medical Group Glendora California 91741 —
California Cancer Care Inc. Greenbrae California 94904 —
Pacific Shores Medical Group Huntington Beach California 92648 —
Santa Barbara Hematology Oncology Medical Group Lompoc California 93438 —
Pacific Shores Medical Group Long Beach California 90813 —
Pacific Shores Medical Group Los Alamitos California 90720 —
UCLS Medical Center Los Angeles California 90095 —
Facey Medical Foundation Mission Hills California 91345 —
North Valley Hematology-Oncology Medical Group Mission Hills California 91345 —
Hoag Cancer Center Newport Beach California 92658 —
North Valley Hematology/Oncology Medical Group Northridge California 91328 —
Ventura County Hematology-Oncology Specialists Oxnard California 93030 —
UCLA Medical Group/Pasadena Oncology Pasadena California 91105 —
Wilshire Oncology Medical Group Pasadena California 91105 —
Wilshire Oncology Medical Group Pomona California 91767 —
Southwest Cancer Care Poway California 92064 —
Wilshire Oncology Medical Group Rancho Cucamonga California 91730 —
Cancer Care Associates Meidcal Group, Inc. Redondo Beach California 90277 —
UC Davis Cancer Center Sacramento California 95817 —
Sansum Santa Barbara Foundation Medical Clinic Santa Barbara California 93105 —
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105 —
Santa Barbara Hematology Oncology Medical Group Santa Maria California 93454 —
John Wayne Cancer Institute Santa Monica California 90404 —
Santa Barbara Hematology Oncology Medical Group Solvang California 93463 —
Cancer Care Associates Medical Group, Inc. Torrance California 90505 —
UCLA/Santa Clarita Valley Cancer Center Valencia California 91355 —
Ventura County Hematology-Oncology Specialists Ventura California 93003 —
San Diego Cancer Center Medical Group Vista California 92083 —
Wilshire Oncology Medical Group West Covina California 91790 —
Whittingham Cancer Center Norwalk Connecticut 06856 —
Division of Hematology/Oncology, University of Miami, School of Medicine Miami Florida 33136 —
Cancer Research Center of Hawaii Honolulu Hawaii 96813 —
Northwestern University Medical School Chicago Illinois 60611 —
Oncology Specialists,S.C. Park Ridge Illinois 60068 —
Cancer Care Center Bloomington Indiana 47403 —
Indiana Oncology and Hematology Consultants Indianapolis Indiana 46202 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Consultants in Blood Disorders and Cancer Louisville Kentucky 40207 —
Hematology and Oncology Specialists, LLC New Orleans Louisiana 70115 —
Louisiana State University Health Sciences Center and VA Shreveport Louisiana 71130 —
Maine Center for Cancer Medicine & Blood Disorders Scarborough Maine 04074 —
Kansas City Oncology and Hematology Group Kansas City Missouri 64111 —
Benefis Healthcare Great Falls Montana 59405 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109 —
Northern New Jersey Cancer Associates Hackensack New Jersey 07601 —
Erie County Medical Center Buffalo New York 14215 —
Advanced Oncology Associates New Rochelle New York 10801 —
Weill Medical College of Cornell University/New York Presbyterian Hospital New York New York 10021 —
Mount Sinai School of Medicine New York New York 10029 —
East Carolina University School of Medicine, Department of Medicine, Division of Hematology/Oncology Greenville North Carolina 27858-4354 —
Gabrail Cancer Center Canton Ohio 44718 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus Ohio 43210 —
Hematology Oncology Consultants, Inc. Columbus Ohio 43235 —
Oregon Health & Science University Portland Oregon 97201 —
Cancer Centers of the Carolinas Greenville South Carolina 29605 —
Germantown Cancer Foundation Germantown Tennessee 38138 —
Fletcher Allen Health Care Burlington Vermont 05401 —
Virginia Cancer Institute Richmond Virginia 23230 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00045877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2006 · Synced Oct 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00045877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →